Please assess the completion status of the following clinical trial:

Trial Title: Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Daily smokers (10 cigarettes per day or more);~* Smokers motivated to make a quit attempt within the next 14 days;~* Potential subjects must be outpatients;~* A subject must have a stable mental and physical medical condition (as per investigator's judgment).~Exclusion Criteria:~* A subject currently eligible for smoking cessation treatment (SCT) reimbursement, whether from a public or a private drug insurance;~* A subject with an unknown drug insurance status;~* A subject living in a household where there is someone already recruited in the study;~* A subject with an unfilled SCT prescription issued within the past three months or with an unused SCT product;~* A subject with a life-threatening illness (ie, known or suspected cancer or other disease with a life expectancy of less than one year).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Full Smoking Cessation Treatment Coverage (100%) (Type: OTHER): A subject randomized to the intervention group will be eligible for smoking cessation treatment (SCT) reimbursement during the 26-week period following the randomization.
- No Smoking Cessation Treatment Coverage (0%) (Type: OTHER): Subjects in the control group choosing to quit using an SCT method will not be eligible for smoking cessation treatment (SCT) reimbursement and, thus, will have to purchase their treatment out of pocket.

Based on this trial design, predict the completion outcome and termination type (if applicable).